By Tony Fong

NEW YORK (GenomeWeb News) – Flush with cash, firms in the life science tools and molecular diagnostics spaces have embarked on stock buyback programs, signaling an end to a hoarding of cash and improving optimism about the state of the economy and their businesses.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.